North America, Europe, and Australia Peanut Allergy Treatment Market
- 2026 年市場規模
- USD 1,345.8 Mn
- 2033 年預估規模
- USD 1,876.4 Mn
- 年複合成長率 CAGR
- 12.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
North America, Europe, and Australia Peanut Allergy Treatment Market, By Drug Type (Epinephrine, Antihistamine, (Loratadine, Diphenhydramine, Others), Palforzia, Pipeline Drugs (Viaskin Peanut, Ligelizumab, CA002, PRT120, Dupilumab)), By Route of Administration (Oral, Parenteral, Intranasal and Epicutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Australia)
報告摘要
Peanut allergy is an allergic response by individual on exposure to peanuts. The most severe allergic reaction to peanuts is anaphylaxis a life-threatening whole-body response to an allergen. Anaphylaxis should be treated immediately with epinephrine (adrenaline), typically administered in an auto-injector. Diagnosing a peanut allergy can be complicated. Symptoms can vary from person to person, and a single individual may not always experience the same symptoms during every reaction.
Market Dynamics
Key players operating in the North America, Europe, and Australia peanut allergy treatment market are focusing on adoption of growth strategies such as product approval for the treatment of peanut allergy which are expected to drive market growth during the forecast period. For instance, In September 2021, COUR Pharmaceuticals, a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) accepted the company's Investigational New Drug (IND) application for evaluation of COUR's CNP-201 in a proof-of-concept (Phase 1 / 2) study in people who are allergic to peanuts. Moreover, increasing adoption of inorganic growth strategies by market players and government organizations is expected to drive the market growth over the forecast period. For instance, in December 2021, the National Health Service, U.K., announced that the department of health signed an agreement with Aimmune Therapeutics, Inc., a Nestlé Health Science company to provide Palforzia in the U.K. The U.K. will be the first country to receive Palforzia in Europe.
Key features of the study
• This report provides in-depth analysis of the North America, Europe, and Australia peanut allergy treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the North America, Europe, and Australia peanut allergy treatment market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, and Strategies
• Key companies covered as a part of this study include, DBV Technologies DBV Technologies, Aimmune Therapeutics, Inc., Prota Therapeutics Pty Ltd., COUR Pharmaceuticals, BlueWillow Biologics, HAL Allergy B.V., Allergy Therapeutics PLC., Novartis AG, Regeneron Pharmaceuticals, Inc., Vedanta Biosciences, Inc., Cambridge Allergy Ltd. (Camallergy), Angany Inc., Moonlight Therapeutics Inc., Allero Therapeutics B.V., Sanofi, Johnson & Johnson, Viatris Inc. (Mylan N.V.), Sun Pharmaceutical Industries Ltd., Bayer AG, Aurobindo Pharma Limited., Astellas Pharma Inc., Siolta Therapeutics, DESENTUM OY, ALK, Immunomic Therapeutics, Inc., and Stallergenes Greer Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The North America, Europe, and Australia peanut allergy treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the North America, Europe, and Australia peanut allergy treatment market.
Market Segmentation
• By Drug Type
o Epinephrine
o Antihistamine
Loratadine
Diphenhydramine
Others
o Palforzia
o Pipeline Drugs
Viaskin Peanut
Ligelizumab
CA002
PRT120
Dupilumab
• By Route of Administration
o Oral
o Parenteral
o Intranasal
o Epicutaneous
• By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Regional Insights
o North America
U.S.
Canada
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Australia
• Key Players Insights
o DBV Technologies
o Aimmune Therapeutics, Inc.
o Prota Therapeutics Pty Ltd.
o COUR Pharmaceuticals
o BlueWillow Biologics
o HAL Allergy B.V.
o Allergy Therapeutics PLC.
o Novartis AG
o Regeneron Pharmaceuticals, Inc.
o Vedanta Biosciences, Inc.
o Cambridge Allergy Ltd. (Camallergy)
o Angany Inc.
o Moonlight Therapeutics Inc.
o Allero Therapeutics B.V.
o Sanofi
o Johnson & Johnson
o Viatris Inc. (Mylan N.V.)
o Sun Pharmaceutical Industries Ltd.
o Bayer AG
o Aurobindo Pharma Limited.
o Astellas Pharma Inc.
o Siolta Therapeutics
o DESENTUM OY
o ALK
o Immunomic Therapeutics, Inc.
o Stallergenes Greer Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Drug Type
Market Snapshot, By Route of Administration
Market Snapshot, By Distribution Channels
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Opportunity
o Impact Analysis
o Key developments
o Pipeline Analysis
o Collaborations and Agreements
o Market Trends
o Product Approval
o Regulatory Scenario
o PEST Analysis
o PORTER’s Five Forces Analysis
o Reimbursement Scenario
o Prescriber Preference: Overview
o Prescriber Overview
o Treatment Algorithm
o Epidemiology
4. North America Europe and Australia Peanut Allergy Treatment Market, By Drug Type, 2026-2033, (USD Mn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2020-2033
Segment Trends
o Epinephrine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
o Antihistamine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
o Loratadine
o Diphenhydramine
o Others
Palforzia
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
Pipeline Drugs
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
Viaskin Peanut
Ligelizuma
CA002
PRT120
Dupilumab
5. North America Europe and Australia Peanut Allergy Treatment Market, By Route of Administration, 2026-2033, (USD Mn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2020-2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
o Parenteral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
o Intranasal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
o Epicutaneous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
6. North America Europe and Australia Peanut Allergy Treatment Market, By Distribution Channel, 2026-2033, (USD Mn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2020-2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2033,(USD Mn)
7. North America Europe and Australia Peanut Allergy Treatment Market, By Region, 2026-2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2020–2031
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2033,(USD Mn)
o U.S.
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Sub-region, 2020-2033,(USD Mn)
o Canada
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020-2033,(USD Mn)
o U.K.
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
o Germany
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
o France
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
o Italy
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
o Spain
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
o Russia
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
o Rest of Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
o Australia
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2033,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2033,(USD Mn)
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
DBV Technologies
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Aimmune Therapeutics, Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Prota Therapeutics Pty Ltd
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
COUR Pharmaceuticals
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
BlueWillow Biologics
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
HAL Allergy B.V
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Allergy Therapeutics PLC
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Novartis AG
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Regeneron Pharmaceuticals, Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Vedanta Biosciences, Inc
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Cambridge Allergy Ltd. (Camallergy)
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Angany Inc
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Moonlight Therapeutics Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Moonlight Therapeutics Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Allero Therapeutics B.V.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Sanofi
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Johnson & Johnson
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Viatris Inc. (Mylan N.V.)
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Sun Pharmaceutical Industries Ltd
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Bayer AG
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Aurobindo Pharma Limited.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Astellas Pharma Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Astellas Pharma Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Siolta Therapeutics
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
DESENTUM OY
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
ALK
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Immunomic Therapeutics, Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Stallergenes Greer Ltd
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
9. Section
o Research Methodology
o About Us and Services
o Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們